Amino Acid Precursors for ADHD

Medication is the pillar of the mainstream treatment model for ADHD. While the rationale is straightforward—by altering neurotransmitter levels, we alter mood and attention—the real-world implications are not. ADHD medications often come with side effects. Worse, some patients do not respond well to medications, a problem many clinicians try to solve by adding more medications.

FACT: Medications are not the only agents that can regulate neurotransmitters! Nearly all neurotransmitters, as well as the enzymes that build them, are constructed from amino acid precursors (e.g., tyrosine and phenylalanine, amino acid precursors for dopamine). When lacking sufficient essential amino acid precursors, the body is incapable of maintaining optimal neurotransmitter levels.

This fact illuminates a potential avenue for the treatment of ADHD through the support of neurotransmitter production. In this webinar, Dr. James Greenblatt will examine a cornerstone of his groundbreaking Plus-Minus® approach: the use of amino acid precursors. You’ll learn how neurotransmitter production is dependent upon amino acid availability, as well as factors contributing to characteristically low amino levels in ADHD patients. Finally, Dr. Greenblatt will present his expert treatment recommendations for optimizing neurotransmitter production and activity through the use of targeted amino acid supplementation.